Prenetics Global Ltd (PRE)
4.81
-0.07
(-1.43%)
USD |
NASDAQ |
Nov 14, 16:00
4.49
-0.32
(-6.65%)
After-Hours: 20:00
Prenetics Global Enterprise Value: 9.425M for Nov. 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 14, 2024 | 9.425M |
| November 13, 2024 | 10.28M |
| November 12, 2024 | 5.516M |
| November 11, 2024 | 6.301M |
| November 08, 2024 | 6.860M |
| November 07, 2024 | 4.783M |
| November 06, 2024 | -0.0651M |
| November 05, 2024 | 4.783M |
| November 04, 2024 | 3.928M |
| November 01, 2024 | 7.104M |
| October 31, 2024 | 7.348M |
| October 30, 2024 | 7.350M |
| October 29, 2024 | 8.937M |
| October 28, 2024 | 8.937M |
| October 25, 2024 | 7.593M |
| October 24, 2024 | 8.204M |
| October 23, 2024 | 8.448M |
| October 22, 2024 | 7.715M |
| October 21, 2024 | 11.01M |
| October 18, 2024 | 12.97M |
| October 17, 2024 | 11.62M |
| October 16, 2024 | 12.97M |
| October 15, 2024 | 14.56M |
| October 14, 2024 | 4.294M |
| October 11, 2024 | 3.072M |
| Date | Value |
|---|---|
| October 10, 2024 | 1.972M |
| October 09, 2024 | -1.937M |
| October 08, 2024 | 1.851M |
| October 07, 2024 | 6.860M |
| October 04, 2024 | 11.01M |
| October 03, 2024 | 3.194M |
| October 02, 2024 | 1.240M |
| October 01, 2024 | 2.706M |
| September 30, 2024 | -0.4707M |
| September 27, 2024 | 0.9343M |
| September 26, 2024 | 1.851M |
| September 25, 2024 | -1.448M |
| September 24, 2024 | 1.973M |
| September 23, 2024 | 2.462M |
| September 20, 2024 | 3.928M |
| September 19, 2024 | 3.928M |
| September 18, 2024 | 5.943M |
| September 17, 2024 | 7.470M |
| September 16, 2024 | 6.921M |
| September 13, 2024 | 5.638M |
| September 12, 2024 | 5.394M |
| September 11, 2024 | 8.692M |
| September 10, 2024 | 6.739M |
| September 09, 2024 | 6.738M |
| September 06, 2024 | 10.04M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-105.01M
Minimum
Aug 24 2023
816.83M
Maximum
May 18 2022
52.05M
Average
2.706M
Median
Oct 01 2024
Enterprise Value Benchmarks
| Sino Biopharmaceutical Ltd | 8.600B |
| HUTCHMED (China) Ltd | 2.171B |
| Pharmaron Beijing Co Ltd | -- |
| Regencell Bioscience Holdings Ltd | 71.42M |
| Uni-Bio Science Group Ltd | 13.51M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.72M |
| Revenue (Quarterly) | 5.942M |
| Total Expenses (Quarterly) | 17.30M |
| EPS Diluted (Quarterly) | -0.88 |
| Gross Profit Margin (Quarterly) | 63.42% |
| Profit Margin (Quarterly) | -180.5% |
| Earnings Yield | -90.44% |
| Normalized Earnings Yield | -78.16 |